Raquel Hladun Alvaro I hold a degree in Medicine and Surgery from the Universitat de Barcelona and completed my medical residency in Pediatrics and its Specific Areas at Vall d’Hebron University Hospital. I undertook a fellowship in Pediatric Oncology and Hematology at Vall d’Hebron Hospital in Barcelona and completed my training with a fellowship in new drug development at Gustave Roussy, an internationally renowned center for pediatric cancer treatment. Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca Doctor Paediatric Oncology and Haematology Children's Hospital and Woman's Hospital Email Raquel Hladun Alvaro Email Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca Doctor Paediatric Oncology and Haematology Children's Hospital and Woman's Hospital I hold a degree in Medicine and Surgery from the Universitat de Barcelona and completed my medical residency in Pediatrics and its Specific Areas at Vall d’Hebron University Hospital. I undertook a fellowship in Pediatric Oncology and Hematology at Vall d’Hebron Hospital in Barcelona and completed my training with a fellowship in new drug development at Gustave Roussy, an internationally renowned center for pediatric cancer treatment.
Since 2017, I have worked as a Consultant in the Pediatric Oncology Department at Vall d’Hebron Hospital. I am currently responsible for pediatric soft tissue sarcomas, pediatric liver tumors, and pediatric precision medicine. I am also part of the Childhood Cancer Research Group at the Vall d’Hebron Institute of Research (VHIR), where I actively participate in the Sarcoma Laboratory and the Personalized Medicine Program. I serve as the National Coordinator in Spain for the clinical trial FaR-RMS for newly diagnosed and relapsed patients, developed by the European Pediatric Soft Tissue Sarcoma Group (EpSSG). I lead the Soft Tissue Sarcoma Working Group of the Sociedad Española de Hematología y Oncología Pediátricas (SEHOP) and am an active member of the EpSSG Phase I/II Committee. I am also part of SEHOP’s Personalized Medicine Working Group and a member of the European consortium Innovative Therapies for Children with Cancer (ITCC). I participate as a co-investigator in major personalized medicine projects, such as the European program MAPPYACTS (MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification) and the national program SEHOP-PENCIL (Personalised mEdiciNe for Cancer in chILdren in Spain).
Projects Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders IP: Lucas Moreno Martín-Retortillo Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00638 Duration: 01/01/2022 - 30/06/2025 Desarrollo de nuevos fármacos basados en la inhibición de los co-receptores de la vía Hedgehog IP: Josep Roma Castanyer Collaborators: Soledad Gallego Melcón, Guillem Pons Barcons, Constantino Sábado Álvarez, Raquel Hladun Alvaro, Patricia Zarzosa Martinez Funding agency: Instituto de Salud Carlos III Funding: 122815 Reference: PI21/00640 Duration: 01/01/2022 - 31/12/2025 Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain IP: Lucas Moreno Martín-Retortillo Collaborators: Aroa Soriano Fernández, Miguel Segura Ginard, Lorena Valero Arrese, Raquel Hladun Alvaro, Elena Antima Martinez Saez, Marta Sese Faustino, Gabriela Guillén Burrieza, Josep Roma Castanyer, Andrea Vilaplana Blanes, Estela Carrasco López, Margarita Ortega Blanco, Implementation and new biomarker development for Personalised Medicine for Childhood Cancers in Spain, Asbleidy Carolina Torres Barbosa, Berta Campos Estela Funding agency: Instituto de Salud Carlos III Funding: 369260 Reference: PMP21/00073 Duration: 01/01/2022 - 31/12/2025 Next generation personalised medicine for childhood cancers IP: Lucas Moreno Martín-Retortillo Collaborators: Aroa Soriano Fernández, Jessica Camacho Soriano, Raquel Hladun Alvaro, Gabriela Guillén Burrieza, Andrea Vilaplana Blanes, Lorena Valero Arrese, Mariona Morell Daniel Funding agency: Instituto de Salud Carlos III Funding: 214170 Reference: PI21/01661 Duration: 01/01/2022 - 30/06/2026 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page »
